MiR‑599 serves a suppressive role in anaplastic thyroid cancer by activating the T‑cell intracellular antigen

Experimental and Therapeutic Medicine ◽

10.3892/etm.2019.7864 ◽

2019 ◽

Author(s):

Jian Bi ◽

Yan Zou ◽

Jian Qian ◽

Wen Chen

Keyword(s):

Thyroid Cancer ◽

T Cell ◽

Anaplastic Thyroid Cancer ◽

Intracellular Antigen

Download Full-text

Abstract 2738: PD-L1/PD-1 checkpoint inhibition in anaplastic thyroid cancer and enhancement of ICAM1-targeted chimeric antigen receptor (CAR)-T cell tumor lysis

10.1158/1538-7445.am2018-2738 ◽

2018 ◽

Author(s):

Katherine D. Gray ◽

Yogindra Vedvyas ◽

Olivia Kalloo ◽

Enda Shevlin ◽

Theresa Scognamiglio ◽

...

Keyword(s):

Thyroid Cancer ◽

T Cell ◽

Chimeric Antigen Receptor ◽

Antigen Receptor ◽

Anaplastic Thyroid Cancer ◽

Checkpoint Inhibition ◽

Tumor Lysis ◽

Download Full-text

In a Novel Malignant Pleural Effusion Derived Anaplastic Thyroid Cancer Line PD-L1 Expression is Strongly Increased by HDAC Inhibitor Treatment

10.1055/s-0039-1678390 ◽

2019 ◽

Author(s):

Luca Hegedűs ◽

Dominika Rittler ◽

Tamás Garay ◽

Paul Stockhammer ◽

Ildikó Kovács ◽

...

Keyword(s):

Thyroid Cancer ◽

Pleural Effusion ◽

Hdac Inhibitor ◽

Malignant Pleural Effusion ◽

Anaplastic Thyroid Cancer ◽

Cancer Line ◽

Inhibitor Treatment

Download Full-text

The two tyrosine kinase inhibitors, CLM29 and CLM3, have antineoplastic activity in primary cultures from anaplastic thyroid cancer obtained from fine needle aspiration

Endocrine Abstracts ◽

10.1530/endoabs.37.ep867 ◽

2015 ◽

Author(s):

Silvia Martina Ferrari ◽

Poupak Fallahi ◽

Concettina La Motta ◽

Gabriele Materazzi ◽

Francesca Ragusa ◽

...

Keyword(s):

Thyroid Cancer ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Fine Needle Aspiration ◽

Kinase Inhibitors ◽

Primary Cultures ◽

Anaplastic Thyroid Cancer ◽

Needle Aspiration ◽

Antineoplastic Activity ◽

Download Full-text

Neural stem cells expressing cytosine deaminase and interferon-[beta] suppressed the growth and metastasis of anaplastic thyroid cancer cells

Endocrine Abstracts ◽

10.1530/endoabs.56.gp236 ◽

2018 ◽

Author(s):

Hye-Ji Shin ◽

Kyung-Chul Choi

Keyword(s):

Thyroid Cancer ◽

Neural Stem Cells ◽

Cancer Cells ◽

Interferon Beta ◽

Cytosine Deaminase ◽

Anaplastic Thyroid Cancer ◽

Thyroid Cancer Cells

Download Full-text

Anaplastic thyroid cancer: a diagnostic and therapeutic challenge

Endocrine Abstracts ◽

10.1530/endoabs.56.p1199 ◽

2018 ◽

Author(s):

Alexandra Mirica ◽

Rodica Petris ◽

Radu Mirica ◽

Sorin Paun ◽

Corin Badiu ◽

...

Keyword(s):

Thyroid Cancer ◽

Anaplastic Thyroid Cancer ◽

Therapeutic Challenge

Download Full-text

Orphan designation: 2-Methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]-phenol, Treatment of anaplastic thyroid cancer

Case Medical Research ◽

10.31525/cmr-1336911 ◽

2019 ◽

Author(s):

Keyword(s):

Thyroid Cancer ◽

Anaplastic Thyroid Cancer ◽

Orphan Designation ◽

Phenol Treatment

Download Full-text

FDA approves new uses for two drugs administered together for the treatment of BRAF-positive anaplastic thyroid cancer

Case Medical Research ◽

10.31525/fda2-ucm606686.htm ◽

2018 ◽

Author(s):

Keyword(s):

Thyroid Cancer ◽

Anaplastic Thyroid Cancer

Download Full-text

Faculty Opinions recommendation of A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717953610.793459214 ◽

2012 ◽

Author(s):

John H Lazarus

Keyword(s):

Thyroid Cancer ◽

Anaplastic Thyroid Cancer ◽

Phase 2 ◽

Download Full-text

Faculty Opinions recommendation of Efatutazone, an oral PPAR-γ agonist, in combination with paclitaxel in anaplastic thyroid cancer: results of a multicenter phase 1 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718006667.793477593 ◽

2013 ◽

Author(s):

Luca Persani

Keyword(s):

Thyroid Cancer ◽

Phase 1 ◽

Anaplastic Thyroid Cancer ◽

Phase 1 Trial ◽

Ppar Γ ◽

Multicenter Phase

Download Full-text

Faculty Opinions recommendation of Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725308809.793541380 ◽

2018 ◽

Author(s):

Maria Cabanillas

Keyword(s):

Thyroid Cancer ◽

Exome Sequencing ◽

Whole Exome Sequencing ◽

Anaplastic Thyroid Cancer ◽

Mutational Landscape ◽

Download Full-text